Anzeige
Meldung des Tages: Antimon Engpässe: Armory Mining wird zum strategischen Anker in der neuen Sicherheitsarchitektur

CytoSorbents News

Aktie
WKN:  A12GDU ISIN:  US23283X2062 US-Symbol:  CTSO Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
0,5399 $
-0,0016 $
-0,30%
0,46774 € 17:17:21 Uhr
Depot/Watchlist
Marktkapitalisierung *
31,67 Mio. €
Streubesitz
58,19%
KGV
-3,96
Index-Zuordnung
-

CytoSorbents News

25.03.26 - PR Newswire
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights PR Newswire
19.03.26 - PR Newswire
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 PR Newswire
05.03.26 - PR Newswire
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights PR Newswire
12.01.26 - PR Newswire
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update PR Newswire
10.12.25 - PR Newswire
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 PR Newswire
17.11.25 - PR Newswire
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire
13.11.25 - PR Newswire
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire
11.11.25 - PR Newswire
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire
30.10.25 - PR Newswire
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire
28.10.25 - PR Newswire
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer PR Newswire
29.09.25 - PR Newswire
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen PR Newswire
16.09.25 - PR Newswire
CytoSorbents Provides DrugSorb-ATR Regulatory Update
CytoSorbents Provides DrugSorb-​ATR Regulatory Update PR Newswire
08.09.25 - PR Newswire
CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day
CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day PR Newswire
05.09.25 - PR Newswire
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire
20.08.25 - PR Newswire
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-​ATR PR Newswire
07.08.25 - PR Newswire
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update PR Newswire
31.07.25 - PR Newswire
CytoSorbents Leads a New Era in Sepsis Treatment
CytoSorbents Leads a New Era in Sepsis Treatment PR Newswire
29.07.25 - PR Newswire
CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights PR Newswire
02.07.25 - PR Newswire
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-​ATR PR Newswire
24.06.25 - PR Newswire
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR PR Newswire

Newssuche

Videos

newspaper
01.04.26
Saisonalitäten: DAS machst Du falsch!
Viele Trader landen irgendwann bei Saisonalitäten, ziehen diesen stark fundamental basierten Ansatz ... Mehr »